Structure Therapeutics Inc.
GPCRUnited States
14 filed reports · 263 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
14 reports · Mar 2023 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 10 | 1,434 | Mar 2023 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 3 | 1,208 | Dec 2023 to Dec 2025 |
| Quarterly · 10-Q/ASEC EDGAR | 1 | 124 | Jun 2023 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 6, 2026 | 268 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 7, 2026 | 160 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 26, 2026 | 705 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 6, 2025 | 177 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 6, 2025 | 100 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 8, 2025 | 102 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Feb 27, 2025 | 172 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Nov 13, 2024 | 147 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 8, 2024 | 125 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | May 9, 2024 | 124 | Open |
| FY2023 | 10-K | Dec 31, 2023 | Mar 8, 2024 | 331 | Open |
| FY2023 Q3 | 10-Q | Sep 30, 2023 | Nov 17, 2023 | 115 | Open |
Financial data
263 concepts · 2,766 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial252 concepts · 2,649 facts · Dec 2021 to Jul 2026
- Operating lease liability25 · Dec 2022 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents24 · Dec 2021 to Jun 2026
- Stockholders equity (US GAAP)24 · Dec 2021 to Jun 2026
- Accrued expenses and other current liabilities22 · Mar 2022 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value22 · Mar 2022 to Jun 2026
- Allocated share based compensation expense22 · Mar 2022 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect22 · Mar 2022 to Jun 2026
- Comprehensive income net of tax22 · Mar 2022 to Jun 2026
- Depreciation22 · Mar 2022 to Jun 2026
- General and administrative expense (US GAAP)22 · Mar 2022 to Jun 2026
- Impairment losses22 · Mar 2022 to Jun 2026
- Income tax expense benefit22 · Mar 2022 to Jun 2026
- Increase decrease in accounts payable22 · Mar 2022 to Jun 2026
- Increase decrease in operating lease liability22 · Mar 2022 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets22 · Mar 2022 to Jun 2026
- Interest and other income, net22 · Mar 2022 to Jun 2026
- Investment income net amortization of discount and premium22 · Mar 2022 to Jun 2026
- Net cash provided by used in financing activities22 · Mar 2022 to Jun 2026
- Net cash provided by used in investing activities22 · Mar 2022 to Jun 2026
- Net cash provided by used in operating activities22 · Mar 2022 to Jun 2026
- Net income loss22 · Mar 2022 to Jun 2026
- Non-cash lease expense22 · Mar 2022 to Jun 2026
- Operating expenses (US GAAP)22 · Mar 2022 to Jun 2026
- Operating income loss22 · Mar 2022 to Jun 2026
Segment11 concepts · 117 facts · Dec 2023 to Jun 2026
- General and administrative expense (US GAAP)13 · Dec 2023 to Jun 2026
- Income tax expense benefit13 · Dec 2023 to Jun 2026
- Interest and other income, net13 · Dec 2023 to Jun 2026
- Net income loss13 · Dec 2023 to Jun 2026
- Operating expenses (US GAAP)13 · Dec 2023 to Jun 2026
- Operating income loss13 · Dec 2023 to Jun 2026
- Other research and development expense13 · Dec 2023 to Jun 2026
- Single Reporting Segment13 · Dec 2023 to Jun 2026
- Income loss from continuing operations before income taxes extraordinary items noncontrolling interest11 · Dec 2023 to Jun 2026
- Gains on sale of non-financial assets1 · Dec 2025
- Other license income1 · Dec 2025
Segments
117 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments1 member · 117 facts
- Single Reportable117 · Dec 2023 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.